Mordechai Algrably
Chief Executive Officer en REKAH PHARMACEUTICAL INDUSTRY LTD. .
Fortuna: 7 M $ al 31/03/2024
Perfil
Mordechai Algrably is the founder of Ophir Ltd., which was founded in 1992.
He is currently the Chief Executive Officer & Director at Rekah Pharmaceutical Industry Ltd.
and the Chairman & President at Rekah Group.
Mr. Algrably's education includes an undergraduate degree from The Hebrew University of Jerusalem.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/09/2023 | 1 748 439 ( 15.17% ) | 7 M $ | 31/03/2024 |
Cargos activos de Mordechai Algrably
| Empresas | Cargo | Inicio |
|---|---|---|
| REKAH PHARMACEUTICAL INDUSTRY LTD. | Chief Executive Officer | 24/08/1993 |
| Rekah Group | Chairman | 28/06/2010 |
| Ophir Ltd. | Founder | 28/06/2010 |
Formación de Mordechai Algrably.
| The Hebrew University of Jerusalem | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REKAH PHARMACEUTICAL INDUSTRY LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Rekah Group | |
| Ophir Ltd. |
- Bolsa de valores
- Insiders
- Mordechai Algrably
